Google’s Artificial Intelligence may save eyesight

Optical Coherence Tomography (OCT) is what is currently used to diagnose diabetic retinopathy and age-related macular degeneration. The problem with this digital scanning method is that it is highly complex and time-consuming for eye care professionals to analyze. This adds up to time lost in diagnosing and treating as early as possible. Aware of this, […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]

Lucentis beats lasers in treating diabetic retinopathy

A study funded by the National Eye Institute determined that Lucentis injections trumped laser therapy in treating proliferative diabetic retinopathy. The study results were published in the Journal of the American Medical Association online. 305 patients were included in the study with half of them receiving monthly Lucentis injections for three months and then only […]

Annual dilated eye exams crucial for diabetic patients

Diabetic patients are encouraged to get an annual dilated eye exam and with November being Diabetic Eye Disease Awareness Month, prevention strategies are being stressed. Diabetes is the leading cause of new cases of blindness in adults. Close monitoring by an eye care professional can help lessen diabetes’ impact on vision and with diabetics being […]

New imaging device will help diagnose eye diseases at earlier stages

A new eye imaging device developed by OcuSciences determines eye health by measuring patterns and tissues in the eye. The results of these measurements and patterns can help eye care professionals detect eye diseases such as diabetes at an earlier stage. This new device, the OcuMet Beacon, has been in development since 2008. The device […]

Eylea on fast track for diabetic retinopathy treatment

Regeneron Pharmaceuticals announced that the FDA has classified Eylea as a breakthrough therapy to treat diabetic retinopathy in patients who already have diabetic macular edema.This classification expedites the process for Eylea to be FDA approved. Currently, Eylea has FDA approval for treatment of wet age-related macular degeneration, macular edema associated with central retinal vein occlusion […]

Google’s smart lens technology pairs with Alcon

Google has licensed its “smart lens” technology to Alcon for all ocular medical uses. The collaboration between the technology giant and the eye care giant will include developing a “smart lens” to address ocular conditions. The advances that Google has made in miniaturization of electronics will help Alcon in its endeavors to improve the ways […]

VisiVite® Eye Formulas for Diabetic Retinopathy

Diabetics with retinopathy or those who want to avoid retinopathy, would benefit from two VisiVite formulas, a study shows. The study, published in the International Journal of Ophthalmology,  showed that diabetics with retinopathy had lower lutein and zeaxanthin blood levels than those without diabetes. The authors hypothesize that this may be due to poor diet, poor absorption in the face […]

‘Sticky-trap’ therapy helps treat diabetic retinopathy

Researchers at the University of Toronto in Canada have developed a new therapy called ‘sticky-trap’ to treat diabetic retinopathy. ‘Sticky-trap’ is injected into the eye and the binding component within it attaches to the surface of cells and shuts down the abnormal blood vessels within the eye. Diabetic retinopathy causes vision loss when the extra, […]

Inflammation receptor linked to diabetic retinopathy

Researchers are looking at the role that a receptor known as Gpr109a plays in reducing eye inflammation, which could help in treating diabetic retinopathy. Diabetic retinopathy is one of the leading causes of blindness in adults in the United States. A team of scientists discovered that removing the receptor from the retina of non-diabetic mice […]